Clinical experience in ovarian squamous cell carcinoma arising from mature cystic teratoma: A rare entity
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
ObjectiveWe sought to investigate the clinicopathologic features of ovarian squamous cell carcinomas arising from mature cystic teratomas (MCT) and to report our clinical experience and lessons learned. MethodsFrom January 1993 to November 2012, a total of 6,260 women with ovarian MCT were surgically treated at Cheil General Hospital and Women’s Healthcare Center. Among them, the cases with malignant transformation to squamous cell carcinoma were included in this analysis. Patient demographic characteristics, surgical findings, and prognosis were evaluated retrospectively. ResultsOf the 6,260 ovarian MCT patients, four (0.06%) had ovarian squamous cell carcinoma arising from MCT. The mean patient age was 43 years (range, 35.51 years), and the mean tumor size was 12 cm (range, 9.16 cm), with two patients in the International Federation of Gynecology and Obstetrics stage I and the other two in stage III. Upon preoperative imaging, all cases were expected to be benign ovarian tumors, but the preoperative squamous cell carcinoma antigen level was elevated from 1.5 ng/mL in stage Ia to 11.3 ng/mL in stage IIIc, suggesting malignancy, while the CA-125 level was normal in two of the three patients who received the test. Optimal debulking surgery was performed and adjuvant chemotherapy was used in all patients, but death from the recurrence of disease occurred in one patient, whose overall survival was 10 months. ConclusionOvarian squamous cell carcinoma arising from MCT is extremely rare, and it is rarely diagnosed preoperatively on imaging workups. Measuring the squamous cell carcinoma antigen level might be a useful diagnostic clue, and it might also be predictive of the tumor stage. An adequate staging surgery should be included in the standard treatment, but multicenter studies are needed to confirm this.
Abstract
ObjectiveWe sought to investigate the clinicopathologic features of ovarian squamous cell carcinomas arising from mature cystic teratomas (MCT) and to report our clinical experience and lessons learned. MethodsFrom January 1993 to November 2012, a total of 6,260 women with ovarian MCT were surgically treated at Cheil General Hospital and Women’s Healthcare Center. Among them, the cases with malignant transformation to squamous cell carcinoma were included in this analysis. Patient demographic characteristics, surgical findings, and prognosis were evaluated retrospectively. ResultsOf the 6,260 ovarian MCT patients, four (0.06%) had ovarian squamous cell carcinoma arising from MCT. The mean patient age was 43 years (range, 35.51 years), and the mean tumor size was 12 cm (range, 9.16 cm), with two patients in the International Federation of Gynecology and Obstetrics stage I and the other two in stage III. Upon preoperative imaging, all cases were expected to be benign ovarian tumors, but the preoperative squamous cell carcinoma antigen level was elevated from 1.5 ng/mL in stage Ia to 11.3 ng/mL in stage IIIc, suggesting malignancy, while the CA-125 level was normal in two of the three patients who received the test. Optimal debulking surgery was performed and adjuvant chemotherapy was used in all patients, but death from the recurrence of disease occurred in one patient, whose overall survival was 10 months. ConclusionOvarian squamous cell carcinoma arising from MCT is extremely rare, and it is rarely diagnosed preoperatively on imaging workups. Measuring the squamous cell carcinoma antigen level might be a useful diagnostic clue, and it might also be predictive of the tumor stage. An adequate staging surgery should be included in the standard treatment, but multicenter studies are needed to confirm this.
참고문헌 (15)
- Yuen PM, "A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses", Am J Obstet Gynecol, 177, pp.109~114 (1997)
- Ayhan A, "Mature cystic teratomas of the ovary: case series from one institution over 34 years", Eur J Obstet Gynecol Reprod Biol, 88, pp.153~157 (2000)
- Westhoff C, "Benign ovarian teratomas:a population-based case-control study", Br J Cancer, 58, pp.93~98 (1988)
- Comerci JT Jr, "Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature", Obstet Gynecol, 84, pp.22~28 (1994)
- Singh P, "Malignancy associated with benign cystic teratomas (dermoid cysts) of the ovary", Singapore Med J, 29, pp.30~34 (1988)
- Mekaru K, "Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy: a case report", Arch Gynecol Obstet, 278, pp.287~290 (2008)
- Hackethal A, "Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data", Lancet Oncol, 9, pp.1173~1180 (2008)
- 김민경, "난소의 성숙낭성기형종에서 기원한 편평상피세포암의 임상병리학적 고찰", Obstetrics & Gynecology Science, 49(7), pp.1455~1462 (2006), 대한산부인과학회
- 지현영, "난소 성숙낭성기형종의 악성 변화 진단 관련 지표에 관한 연구", Obstetrics & Gynecology Science, 52(12), pp.1258~1264 (2009), 대한산부인과학회
- Kikkawa F, "Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary", Cancer, 82, pp.2249~2255 (1998)
- 강우대, "난소의 성숙 낭성기형종에서 유래한 악성 변형 11예의임상 병리학적 고찰", Obstetrics & Gynecology Science, 47(4), pp.650~655 (2004), 대한산부인과학회
- Chen P, "Squamous cell carcinoma occurring in the pelvis after total hysterectomy and bilateral salpingo-oophorectomy for an ovarian mature teratoma with malignant transformation", Taiwan J Obstet Gynecol, 51, pp.446~448 (2012)
- Park SB, "CT findings of mature cystic teratoma with malignant transformation: comparison with mature cystic teratoma", Clin Imaging, 35, pp.294~300 (2011)
- Tseng CJ, "Squamous cell carcinoma arising in mature cystic teratoma of the ovary", Gynecol Oncol, 63, pp.364~370 (1996)
- Omura G, "A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma: a Gynecologic Oncology Group Study", Cancer, 57, pp.1725~1730 (1986)